V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212972 | 20129070 | 1.73 | null | Adjuvant (A) | 2019-04-04 | 2019-04-29 | null | null | null | NIVOLUMAB | 100447439 |
| 20212976 | 20129071 | null | 74.88 | Palliative (P) | 2017-09-28 | 2017-10-07 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100711760 |
| 20212977 | 20129072 | 1.84 | 61.9 | Neo-adjuvant (N) | 2018-02-28 | 2018-04-05 | Panitumumab | 02 | N | PANITUMUMAB | 101814292 |
| 20212978 | 20129073 | 1.67 | 70.42 | Palliative (P) | 2018-10-30 | 2018-11-23 | Panitumumab | 02 | N | PANITUMUMAB | 101279787 |
| 20212979 | 20129074 | 1.47 | 75.6 | null | null | 2019-02-23 | null | 02 | null | CISPLATIN + FLUOROURACIL | 100197696 |
| 20212988 | 20129075 | 1.63 | null | Palliative (P) | 2017-11-24 | 2017-12-08 | Panitumumab | null | N | PANITUMUMAB | 100217054 |
| 20212990 | 20129076 | null | null | Curative (C) | 2021-07-25 | 2021-07-31 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100837165 |
| 20212993 | 20129077 | 1.76 | 92.35 | Adjuvant (A) | 2020-07-12 | 2020-07-17 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101332520 |
| 20212994 | 20129078 | 1.54 | 68.6 | Adjuvant (A) | 2019-08-03 | 2019-08-03 | ECX | 2 | null | ECX | 101532478 |
| 20212995 | 20129079 | 1.57 | 80 | null | 2020-05-08 | 2020-05-23 | null | 02 | null | CISPLATIN + FLUOROURACIL | 100296693 |
| 20212996 | 20129080 | 1.85 | null | null | 2020-07-27 | 2020-08-10 | CISPLATIN + FLUOROURACIL | N | null | CISPLATIN + FLUOROURACIL | 100906126 |
| 20213001 | 20129084 | 1.57 | 47 | Neo-adjuvant (N) | 2019-03-16 | 2019-04-05 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101608794 |
| 20213005 | 20129085 | 1.73 | null | Palliative (P) | null | 2020-12-12 | Panitumumab | 02 | N | PANITUMUMAB | 100410749 |
| 20213006 | 20129086 | 1.7 | 45 | Palliative (P) | 2018-09-30 | 2018-12-22 | ECX | 02 | N | ECX | 101588646 |
| 20213011 | 20129087 | 1.81 | null | null | null | 2017-10-11 | Panitumumab | 02 | Y | PANITUMUMAB | 101383521 |
| 20213012 | 20129088 | 1.75 | null | Palliative (P) | 2018-07-19 | 2018-07-21 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101747651 |
| 20213016 | 20129089 | null | null | Palliative (P) | 2018-06-23 | 2018-06-23 | ECX | 2 | N | ECX | 101422492 |
| 20213020 | 20129090 | 1.77 | 41.85 | null | null | 2019-12-31 | ECX | 02 | null | ECX | 101342806 |
| 20213021 | 20129091 | 1.79 | null | Palliative (P) | 2019-01-01 | 2019-01-09 | null | 02 | N | NIVOLUMAB | 100668905 |
| 20213022 | 20129092 | 1.7 | 57.8 | null | 2019-03-25 | 2019-03-25 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100835835 |
| 20213023 | 20129093 | 1.56 | 67.9 | Adjuvant (A) | 2021-10-19 | 2021-10-20 | null | N | N | ECX | 101298531 |
| 20213024 | 20129094 | null | 84 | null | 2019-05-10 | 2019-05-17 | null | 02 | null | ECX | 101152468 |
| 20213027 | 20129095 | 1.77 | 58.6 | null | 2018-05-28 | 2018-06-12 | null | 02 | null | NIVOLUMAB | 101562539 |
| 20213031 | 20129096 | 1.75 | 58 | Palliative (P) | 2017-11-28 | 2017-12-04 | Panitumumab | N | N | PANITUMUMAB | 101243785 |
| 20213033 | 20129097 | 1.63 | 111.8 | Palliative (P) | 2016-07-02 | 2019-10-24 | Carboplatin + Etoposide iv&po | null | N | CARBOPLATIN + ETOPOSIDE | 100294929 |
| 20213035 | 20129098 | 1.78 | 88.6 | Curative (C) | 2019-10-19 | 2019-10-19 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101575595 |
| 20213036 | 20129099 | 1.5 | 118.9 | Palliative (P) | null | 2018-03-12 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100729520 |
| 20213039 | 20129100 | 1.67 | 50.8 | Palliative (P) | 2018-03-12 | 2018-04-02 | null | 02 | N | NIVOLUMAB | 101150775 |
| 20213045 | 20129102 | 1.7 | 103.9 | Palliative (P) | 2021-02-06 | 2021-02-10 | Carboplatin + Etoposide iv&po | 02 | N | PANITUMUMAB | 100417278 |
| 20213046 | 20129103 | 1.59 | 75.6 | null | 2019-05-31 | 2019-08-12 | null | 02 | null | NIVOLUMAB | 100763023 |
| 20213049 | 20129105 | 1.63 | 62.1 | null | 2018-09-03 | 2018-09-23 | Panitumumab | 02 | null | PANITUMUMAB | 100684362 |
| 20213051 | 20129106 | null | 109 | null | 2020-02-23 | 2020-03-05 | Cisplatin +Fluorouracil (3 wk) | N | null | CISPLATIN + FLUOROURACIL | 101484682 |
| 20213056 | 20129109 | 1.65 | 96.6 | null | 2020-05-29 | 2020-06-11 | null | 02 | null | NIVOLUMAB | 100415647 |
| 20213057 | 20129110 | null | 83.8 | null | 2017-01-28 | 2017-01-30 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100676880 |
| 20213064 | 20129113 | 1.79 | 86.3 | null | 2021-09-11 | 2021-12-25 | null | null | null | PANITUMUMAB | 100429030 |
| 20213067 | 20129114 | 1.6 | null | Curative (C) | 2016-08-15 | 2016-08-21 | null | null | N | CARBOPLATIN + ETOPOSIDE | 101154886 |
| 20213069 | 20129116 | 1.67 | 83 | null | 2019-09-02 | 2019-09-17 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 100220992 |
| 20213070 | 20129117 | 1.56 | 60 | Palliative (P) | 2017-11-24 | 2017-12-20 | null | 02 | N | ECX | 101683804 |
| 20213073 | 20129119 | null | null | Neo-adjuvant (N) | 2018-10-21 | 2018-10-21 | null | 02 | null | NIVOLUMAB | 100558066 |
| 20213074 | 20129120 | 1.76 | 35.4 | null | 2020-02-14 | 2020-02-16 | null | 02 | null | ECX | 100519227 |
| 20213075 | 20129121 | null | 70 | null | 2017-03-02 | 2017-11-25 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 101135422 |
| 20213076 | 20129122 | 1.64 | null | null | 2020-01-11 | 2020-01-26 | null | 02 | N | NIVOLUMAB | 100088508 |
| 20213078 | 20129123 | 1.64 | 72.6 | Adjuvant (A) | 2019-05-03 | 2019-05-03 | null | 02 | null | PANITUMUMAB | 100811709 |
| 20213080 | 20129124 | null | null | null | 2018-06-30 | 2018-06-30 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101397610 |
| 20213081 | 20129125 | 1.73 | 68 | null | 2018-01-21 | 2018-02-18 | ECX | N | null | ECX | 100646071 |
| 20213082 | 20129126 | 1.69 | 59.8 | Adjuvant (A) | 2018-05-04 | 2018-05-04 | ECX | 02 | N | CARBOPLATIN + ETOPOSIDE | 100982537 |
| 20213090 | 20129128 | 1.55 | 59.55 | Adjuvant (A) | 2019-02-19 | 2019-03-04 | ECX | 2 | null | ECX | 101297525 |
| 20213092 | 20129129 | 1.71 | 74.5 | Curative (C) | 2020-07-26 | 2020-08-17 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101647432 |
| 20213098 | 20129134 | 1.7 | 76.6 | Curative (C) | 2019-09-16 | 2019-12-23 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100525011 |
| 20213099 | 20129135 | 1.81 | 55.5 | Neo-adjuvant (N) | 2018-07-03 | 2018-07-17 | ECX | 02 | N | ECX | 100235673 |